Tenax Therapeutics, Inc. (TENX)
NASDAQ: TENX · Real-Time Price · USD
11.02
+0.33 (3.09%)
At close: Mar 9, 2026, 4:00 PM EDT
11.02
0.00 (0.03%)
After-hours: Mar 9, 2026, 5:37 PM EDT
Tenax Therapeutics Market Cap
Tenax Therapeutics has a market cap or net worth of $447.09 million as of March 9, 2026. Its market cap has increased by 2,039.16% in one year.
Market Cap
447.09M
Enterprise Value
351.77M
1-Year Change
2,039.16%
Ranking
Category
Stock Price
$11.02
Market Cap Chart
Since January 15, 2010, Tenax Therapeutics's market cap has increased from $148.50M to $447.09M, an increase of 201.07%. That is a compound annual growth rate of 7.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 66.70M | -12.35% |
| Dec 31, 2025 | 76.10M | 260.66% |
| Dec 31, 2024 | 21.10M | 219.70% |
| Dec 29, 2023 | 6.60M | 32.00% |
| Dec 30, 2022 | 5.00M | -80.92% |
| Dec 31, 2021 | 26.20M | 11.49% |
| Dec 31, 2020 | 23.50M | 147.37% |
| Dec 31, 2019 | 9.50M | 427.78% |
| Dec 31, 2018 | 1.80M | -86.96% |
| Dec 29, 2017 | 13.80M | -74.82% |
| Dec 30, 2016 | 54.80M | -40.63% |
| Dec 31, 2015 | 92.30M | -14.54% |
| Dec 31, 2014 | 108.00M | 125.94% |
| Dec 31, 2013 | 47.80M | 123.36% |
| Dec 31, 2012 | 21.40M | -45.69% |
| Dec 30, 2011 | 39.40M | -10.86% |
| Dec 31, 2010 | 44.20M | -70.24% |
View and export this data all the way back to 2010.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Assembly Biosciences | 450.95M |
| Anavex Life Sciences | 436.48M |
| 4D Molecular Therapeutics | 436.12M |
| Lineage Cell Therapeutics | 433.77M |
| Relmada Therapeutics | 429.00M |
| Upstream Bio | 426.90M |
| vTv Therapeutics | 423.14M |
| Autolus Therapeutics | 416.51M |